Flubrotizolam has become known as a novel benzodiazepine compound. Synthesized for limited purposes, flubrotizolam possesses remarkable sedative effects. Its structural properties reveal a high affinity for the GABA receptor, leading to significant CNS depression. However its potential therapeutic applications, flubrotizolam's illicit use has risen